Immuno- and Bio-therapies

Program Leader
Dr. John Bell
Ottawa Health Research Institute

Biotherapeutics for cancer treatment uses viruses to kill cancer cells while sparing healthy ones. There is a potential for oncolytic viruses to be developed into vaccines for the treatment of cancer. The Immuno- and Bio-therapies Program is identifying new agents that can selectively destroy cancer cells and minimize the adverse effects experienced by patients receiving current treatments.